Validation of Five Prognostic Models Treated with Axitinib Beyond First-Line Nivolumab Plus Ipilimumab Therapy for Metastatic Renal Cell Carcinoma: a Japanese Multicenter Retrospective Study.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY（2025）
Key words
renal cell carcinoma,systemic therapy,axitinib
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined